Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Lohmann

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Frontiers in Medicine|October 10, 2022
Editorial: "Nuclear medicine in cancer diagnosis"Francesco Cicone, Philipp Lohmann
Neuro-Oncology Practice|November 17, 2022
Imaging patterns in patients with newly diagnosed glioblastoma in EnglandNorbert Galldiks, Philipp Lohmann
Neuro-Oncology Advances|February 1, 2021
Artificial Intelligence, Radiomics, and Deep Learning in Neuro-OncologyNorbert Galldiks, Gelareh Zadeh, Philipp Lohmann
Neuro-Oncology|December 21, 2019
Combined FET PET/ADC mapping: improved imaging of glioma infiltration?Karl-Josef Langen, Norbert Galldiks, Philipp Lohmann
Expert Review of Molecular Diagnostics|June 20, 2020
Imaging challenges following newer treatment options: are companion diagnostics required in neurooncology?Norbert Galldiks, Philipp Lohmann, Karl-Josef Langen
Neuro-Oncology|May 5, 2022
The role of 11C-methionine PET in patients with newly diagnosed WHO grade 2 or 3 gliomasNorbert Galldiks, Philipp Lohmann, Karl-Josef Langen
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 6, 2018
Radiomics derived from amino-acid PET and conventional MRI in patients with high-grade gliomasPhilipp Lohmann, Martin Kocher, Jan Steger, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 11, 2020
Radiomics in radiation oncology-basics, methods, and limitationsPhilipp Lohmann, Khaled Bousabarah, Mauritius Hoevels, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 13, 2020
Applications of radiomics and machine learning for radiotherapy of malignant brain tumorsMartin Kocher, Maximilian I Ruge, Norbert Galldiks, et al.
Current Radiopharmaceuticals|January 15, 2019
O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental ResultsCarina Stegmayr, Antje Willuweit, Philipp Lohmann, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Frontiers in Medicine|October 10, 2022
Editorial: "Nuclear medicine in cancer diagnosis"Francesco Cicone, Philipp Lohmann
Neuro-Oncology Practice|November 17, 2022
Imaging patterns in patients with newly diagnosed glioblastoma in EnglandNorbert Galldiks, Philipp Lohmann
Neuro-Oncology Advances|February 1, 2021
Artificial Intelligence, Radiomics, and Deep Learning in Neuro-OncologyNorbert Galldiks, Gelareh Zadeh, Philipp Lohmann
Neuro-Oncology|December 21, 2019
Combined FET PET/ADC mapping: improved imaging of glioma infiltration?Karl-Josef Langen, Norbert Galldiks, Philipp Lohmann
Expert Review of Molecular Diagnostics|June 20, 2020
Imaging challenges following newer treatment options: are companion diagnostics required in neurooncology?Norbert Galldiks, Philipp Lohmann, Karl-Josef Langen
Neuro-Oncology|May 5, 2022
The role of 11C-methionine PET in patients with newly diagnosed WHO grade 2 or 3 gliomasNorbert Galldiks, Philipp Lohmann, Karl-Josef Langen
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 6, 2018
Radiomics derived from amino-acid PET and conventional MRI in patients with high-grade gliomasPhilipp Lohmann, Martin Kocher, Jan Steger, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 11, 2020
Radiomics in radiation oncology-basics, methods, and limitationsPhilipp Lohmann, Khaled Bousabarah, Mauritius Hoevels, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 13, 2020
Applications of radiomics and machine learning for radiotherapy of malignant brain tumorsMartin Kocher, Maximilian I Ruge, Norbert Galldiks, et al.
Current Radiopharmaceuticals|January 15, 2019
O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental ResultsCarina Stegmayr, Antje Willuweit, Philipp Lohmann, et al.
Pageof 14